To really get the best result from the underwriter and the most competitive pricing and terms for the insureds, it really helps for brokers to be additive in the process as opposed to just being transactional.
What you need for a claims role is to be naturally inquisitive and analytical in the way you approach a claim. You need to look at things from a very process-forward analytical state.
Despite declining transaction volume in 2024, life sciences companies are pursuing bigger acquisitions to secure drug portfolios, integrate AI capabilities, and navigate the looming patent cliff.
As AI reshapes the competitive landscape, technology companies are pursuing bigger acquisitions despite declining deal volume, with blockbuster transactions exceeding $30 billion becoming the new normal.